/* ============================================
   faqs.js  （保存先：faq/data/faqs.js）
   ★ このファイルは「FAQデータだけ」を持つ
   ★ ここに新しいFAQを追記していけばOK（Q69, Q70…）
   ★ 他のJSからは window.FAQS を参照する
============================================ */
(function(){
  // ★ 合体配列を用意（既にあれば使う）
  window.FAQS = window.FAQS || [];

  // ★ ここからFAQ本体
  window.FAQS.push(
    {"id":"Q1","question":"Is every citizen in Japan covered by health insurance?","answer":"In Japan, all registered residents are required to enroll in public health insurance (either Employee's Health Insurance or National Health Insurance), ensuring universal coverage for necessary medical services.","categories":["System"],"primary":"System"},
    {"id":"Q2","question":"What percentage of medical expenses do patients typically pay out of pocket in Japan?","answer":"Generally 30% of the medical fee is paid at the point of care (10–30% depending on age and income categories), with the remainder covered by public insurance.","categories":["System"],"primary":"System"},
    {"id":"Q3","question":"Is there an upper limit to out-of-pocket payments for medical expenses in Japan?","answer":"Yes. The High-Cost Medical Expense Benefit sets a monthly cap on patient cost sharing, with thresholds varying by age and income; amounts exceeding the cap are reimbursed.","categories":["System","Patients"],"primary":"System"},
    {"id":"Q4","question":"Does the design of the healthcare payment system influence behaviors in clinical practice?","answer":"Yes. Uniform fee schedules and insurance rules shape practice patterns (e.g., test ordering, referral behaviors), and operational constraints influence daily workflow and time allocation.","categories":["System","HCP","Operations"],"primary":"System"},
    {"id":"Q5","question":"Is access to healthcare providers in Japan open and flexible?","answer":"Yes. Patients can generally visit their preferred facility without strict gatekeeping; however, large hospitals may require referral letters or additional fees for first visits.","categories":["System","Patients"],"primary":"System"},
    {"id":"Q6","question":"What challenges are associated with a system where anyone can freely access large hospitals or specialists?","answer":"It can cause overcrowding at tertiary hospitals, longer waiting times, and potential inefficiency; triage by referrals and differential fees are used to encourage appropriate access.","categories":["System","Patients","Operations"],"primary":"System"},
    {"id":"Q7","question":"Does Japan have a primary care physician system?","answer":"Not in a strict gatekeeping sense. Many clinics function as de facto primary care, but patients retain freedom to visit specialists directly.","categories":["System"],"primary":"System"},
    {"id":"Q8","question":"Are there any restrictions on physicians' clinical practices or referral pathways in Japan?","answer":"Clinical freedom is respected, but institutional protocols and insurance rules (including documentation requirements) guide referrals and certain procedures.","categories":["System","HCP"],"primary":"System"},
    {"id":"Q9","question":"Are Japan’s health insurance systems operated by private companies?","answer":"The core schemes are public: Employee-based and municipal National Health Insurance. Private insurers play a supplemental role rather than running the public schemes.","categories":["System"],"primary":"System"},
    {"id":"Q10","question":"How are health insurance premiums determined in Japan?","answer":"Employee plan premiums are income-based and shared by employers and employees; National Health Insurance premiums are set by municipalities considering income, household size, and assets.","categories":["System"],"primary":"System"},
    {"id":"Q11","question":"Is there a role for private health insurance in Japan?","answer":"Yes—mainly as supplemental coverage for hospitalization cash benefits or non-covered services; it does not replace the public system.","categories":["System"],"primary":"System"},
    {"id":"Q12","question":"What is the role of physicians and their influence on purchasing decisions in Japan?","answer":"Physicians strongly influence treatment choice and hospital purchasing decisions, especially for device-intensive or specialty areas; however, guidelines and formularies also shape choices.","categories":["HCP","Operations","System"],"primary":"HCP"},
    {"id":"Q13","question":"How is the health checkup system implemented in Japan?","answer":"It is supported by public programs and employers. Periodic checkups (including cancer screening by age) are encouraged with follow-up pathways when abnormalities are detected.","categories":["System","Operations","Patients"],"primary":"System"},
    {"id":"Q14","question":"What types of tests are included in health checkups in Japan?","answer":"Typical sets include physical exam, blood/urine tests, blood pressure, ECG, chest X-ray; age/risk-based items can include GI endoscopy, mammography, and others.","categories":["System","Patients"],"primary":"System"},
    {"id":"Q15","question":"What follow-up system is in place if abnormalities are found during a health checkup in Japan?","answer":"Participants receive referral recommendations or letters to appropriate facilities; follow-up is typically coordinated by clinics/companies, with insurance coverage applying to diagnostic care.","categories":["System","Patients","Operations"],"primary":"System"},
    {"id":"Q16","question":"What are the characteristics of price revisions for medical services and pharmaceuticals in Japan?","answer":"National fee schedules and drug prices undergo periodic revisions (usually every two years), affecting reimbursement levels and prescribing/uptake patterns.","categories":["System","Timeline"],"primary":"System"},
    {"id":"Q17","question":"What types of medical institutions exist in Japan?","answer":"University/tertiary hospitals, general hospitals, specialty centers, and private clinics; roles differ for acute, specialized, and community care.","categories":["System"],"primary":"System"},
    {"id":"Q18","question":"How do patients in Japan choose medical institutions?","answer":"By convenience, reputation, specialty availability, and referrals; universal coverage reduces price differences at point of care, so access and perceived quality matter.","categories":["Patients","System"],"primary":"Patients"},
    {"id":"Q19","question":"What is the number of hospital beds and the availability of medical equipment (such as MRI machines) in Japan?","answer":"Japan has a high number of hospital beds and abundant imaging equipment per capita compared with many countries; availability varies by region and facility type.","categories":["System"],"primary":"System"},
    {"id":"Q20","question":"Is there a formal system for general practitioners (GPs) or general medicine physicians in Japan?","answer":"A formal GP gatekeeping system is not pervasive; \"general internal medicine\" and primary-care-style clinics fulfill first-contact roles, with referrals to specialists as needed.","categories":["System"],"primary":"System"},
    {"id":"Q21","question":"How are medical specialties categorized in Japan?","answer":"Specialties follow national training boards (e.g., internal medicine, surgery, pediatrics) with sub-specialty certification; institutions may have different departmental arrangements.","categories":["HCP","System"],"primary":"HCP"},
    {"id":"Q22","question":"Are there any distinctive features in the Japanese system for medical licensing and board certification?","answer":"National licensing is standardized; specialty board certification has undergone reforms for quality assurance and training program accreditation.","categories":["HCP","System"],"primary":"HCP"},
    {"id":"Q23","question":"Do physicians in Japan see a high number of patients or handle a large number of consultations per doctor?","answer":"Yes, particularly in outpatient clinics; this impacts consultation time and scheduling preferences for research participation.","categories":["HCP","Operations"],"primary":"HCP"},
    {"id":"Q24","question":"Do patients in Japan visit medical institutions frequently?","answer":"Yes; visit frequency is relatively high due to accessibility, chronic disease follow-up, and cultural preferences for in-person care.","categories":["Patients","System"],"primary":"Patients"},
    {"id":"Q25","question":"Are consultation times for doctors in Japan short? If so, why?","answer":"Often shorter than in some countries due to patient volume, workflow, and documentation; efficiency and concise communication are valued.","categories":["HCP","Operations","System"],"primary":"HCP"},
    {"id":"Q26","question":"Are there differences in workload, such as working hours, between hospital-based physicians and clinic-based (private practice) physicians in Japan?","answer":"Yes; hospital physicians manage inpatient/outpatient and call duties, while clinic physicians focus on ambulatory care with more predictable hours.","categories":["HCP","Operations"],"primary":"HCP"},
    {"id":"Q27","question":"Which physicians are responsible for treating cancer patients in Japan?","answer":"Care is multidisciplinary: surgeons, medical oncologists, radiation oncologists, and organ-specific specialists; roles vary by institution.","categories":["HCP","System"],"primary":"HCP"},
    {"id":"Q28","question":"What is the current situation regarding the number and role of medical oncologists in Japan?","answer":"Medical oncology has expanded but remains concentrated; organ-specific oncology remains influential; expertise is centered in major hospitals.","categories":["HCP","System"],"primary":"HCP"},
    {"id":"Q29","question":"Which hospitals or medical institutions play a central role in cancer care in Japan?","answer":"Designated cancer centers, university hospitals, and large regional hospitals coordinate advanced cancer care and clinical trials.","categories":["System","HCP"],"primary":"System"},
    {"id":"Q30","question":"What is the process and what are the characteristics of the adoption and dissemination of new cancer drugs in Japan?","answer":"After regulatory approval and pricing, uptake is influenced by guidelines, hospital formulary decisions, and specialist consensus; dissemination is steady with periodic price reviews.","categories":["System","Timeline","HCP"],"primary":"System"},
    {"id":"Q31","question":"How much importance do Japanese physicians place on clinical guidelines?","answer":"High; guidelines and consensus statements are widely referenced in decision-making and education.","categories":["HCP","Compliance","System"],"primary":"HCP"},
    {"id":"Q32","question":"Are physicians in Japan generally willing to participate in research or surveys?","answer":"Willing but time-constrained; clear purpose, concise instruments, and fair honoraria improve participation rates.","categories":["HCP","Fieldwork","Compliance"],"primary":"HCP"},
    {"id":"Q33","question":"How should the survey duration and format be designed?","answer":"Keep concise with logical flow; for busy HCPs, 20–30 minutes for IDIs is common; use language and examples localized to Japan.","categories":["Fieldwork","Operations","HCP"],"primary":"Fieldwork"},
    {"id":"Q34","question":"Is localization of the survey content and language necessary for Japanese participants?","answer":"Yes—terminology, examples, and regulatory wording should be localized; Japanese materials increase clarity and pace.","categories":["Fieldwork","Compliance","Operations"],"primary":"Fieldwork"},
    {"id":"Q35","question":"Is it culturally acceptable for physicians in Japan to receive honoraria for participating in research?","answer":"Yes within ethical standards; clarity on research purpose, privacy, and tax documentation is expected.","categories":["HCP","Compliance","Operations"],"primary":"HCP"},
    {"id":"Q36","question":"What is the typical range of honoraria for physician participation in research in Japan?","answer":"Ranges vary by specialty/time; benchmark locally; ensure compliance and transparent communication on payment method.","categories":["HCP","Operations","Compliance"],"primary":"HCP"},
    {"id":"Q37","question":"Are there any specific characteristics or preferences regarding payment methods in Japan?","answer":"Bank transfer is common; clear invoicing/receipts and tax considerations should be addressed.","categories":["Operations","Compliance","HCP"],"primary":"Operations"},
    {"id":"Q38","question":"What manners and cultural considerations should be observed when interviewing or meeting with physicians in Japan?","answer":"Use polite forms, begin with appreciation, provide clear structure, and allow reflective pauses; confirm recording and confidentiality.","categories":["Fieldwork","HCP","Compliance"],"primary":"Fieldwork"},
    {"id":"Q39","question":"Are patients in Japan generally reluctant to participate in surveys?","answer":"Reluctance can occur due to privacy concerns and modesty; trust-building, clear consent, and simple language help.","categories":["Patients","Compliance","Fieldwork"],"primary":"Patients"},
    {"id":"Q40","question":"How should highly sensitive or privacy-related questions be handled in surveys?","answer":"Minimize PII, explain purpose and use, and provide opt-outs; ensure anonymization and secure storage.","categories":["Compliance","Fieldwork","Patients"],"primary":"Compliance"},
    {"id":"Q41","question":"What age groups are most commonly represented in patient surveys in Japan?","answer":"Middle to older adults are common given demographics; tailor recruiting and materials for accessibility.","categories":["Patients","Fieldwork"],"primary":"Patients"},
    {"id":"Q42","question":"What considerations or adaptations should be made when conducting surveys with elderly patients in Japan?","answer":"Use larger fonts, simpler structures, slower pace; consider caregiver presence and scheduling flexibility.","categories":["Patients","Fieldwork","Operations"],"primary":"Patients"},
    {"id":"Q43","question":"Are there any other considerations when conducting patient surveys in Japan?","answer":"Be attentive to literacy, regional differences, and clinic partnerships; align screening with clinical pathways.","categories":["Patients","Fieldwork","System"],"primary":"Patients"},
    {"id":"Q44","question":"What are the main channels used for patient recruitment in Japan?","answer":"Clinics/hospitals, advocacy groups, specialized vendors, and carefully screened online panels; social media may support rare diseases.","categories":["Patients","Fieldwork","Compliance"],"primary":"Patients"},
    {"id":"Q45","question":"What roles do pharmacists play in the Japanese healthcare system?","answer":"They manage dispensing, medication counseling, and coordination with prescribers; hospital and community roles differ.","categories":["HCP","System"],"primary":"HCP"},
    {"id":"Q46","question":"From what perspectives should pharmacists be asked for their opinions in research?","answer":"Medication management, adherence, drug utilization, and workflow; perspectives differ by hospital vs. community settings.","categories":["HCP","Fieldwork","Operations"],"primary":"HCP"},
    {"id":"Q47","question":"What are the differences between hospital pharmacists and community (dispensing) pharmacists in Japan?","answer":"Hospital pharmacists engage in inpatient care, rounds, and sterile prep; community pharmacists focus on dispensing, counseling, and coordination.","categories":["HCP","System","Operations"],"primary":"HCP"},
    {"id":"Q48","question":"Are honorarium settings and considerations the same as for physicians?","answer":"Similar principles but different benchmarks; align with role, time, and institutional policies.","categories":["HCP","Operations"],"primary":"HCP"},
    {"id":"Q49","question":"Can nurses be considered as valid target respondents for research in Japan?","answer":"Yes—nurses provide critical insights on care delivery, patient education, and device usability.","categories":["HCP","Fieldwork"],"primary":"HCP"},
    {"id":"Q50","question":"Can caregivers also be included as research participants?","answer":"Yes; caregivers offer perspectives on burden, logistics, and decision-making support.","categories":["Patients","Fieldwork"],"primary":"Patients"},
    {"id":"Q51","question":"What aspects tend to make Japanese research participants feel anxious or doubtful?","answer":"Ambiguous purpose, unclear data use, and complicated consent; address with transparent framing and plain language.","categories":["Patients","Fieldwork","Compliance"],"primary":"Patients"},
    {"id":"Q52","question":"Why is localization particularly important in the Japanese market?","answer":"Localization ensures conceptual equivalence, aligns with regulations, and improves comprehension and pace.","categories":["Fieldwork","Operations","Compliance"],"primary":"Fieldwork"},
    {"id":"Q53","question":"What should we be careful about when translating into Japanese?","answer":"Avoid literalism for idioms; ensure correct clinical terms and regulatory phrasing; add brief cultural context where needed.","categories":["Fieldwork","Operations","Compliance"],"primary":"Fieldwork"},
    {"id":"Q54","question":"What is an appropriate survey length for healthcare professionals and patients in Japan?","answer":"For HCPs, keep interviews concise (often 20–30 minutes); for patients, allow more time and simpler structures.","categories":["Fieldwork","HCP","Patients","Operations"],"primary":"Fieldwork"},
    {"id":"Q55","question":"What are the typical response patterns of Japanese participants to open-ended questions?","answer":"Responses may be concise; use probes and examples; create a safe, respectful atmosphere.","categories":["Fieldwork","Patients","HCP"],"primary":"Fieldwork"},
    {"id":"Q56","question":"Why is an In-Country Review necessary?","answer":"To validate translation, clinical/regulatory fit, and cultural nuance before launch; reduces risk and rework.","categories":["Fieldwork","Operations","Compliance"],"primary":"Fieldwork"},
    {"id":"Q57","question":"Why is qualitative research often perceived as difficult to conduct in Japan?","answer":"Time constraints, modest self-expression norms, and recruitment challenges; mitigated by careful design and moderation.","categories":["Fieldwork","Operations"],"primary":"Fieldwork"},
    {"id":"Q58","question":"Why do Japanese participants tend to be hesitant in sharing their opinions, and how can we effectively draw out their honest thoughts?","answer":"Build rapport, use non-leading questions, and allow silence; normalize differing views to reduce social pressure.","categories":["Fieldwork","Operations"],"primary":"Fieldwork"},
    {"id":"Q59","question":"Japanese participants tend to speak less during interviews. If responses are limited, does it mean the research cannot be considered valid? How should we address this issue?","answer":"Shorter responses do not equal low insight; structure probes, triangulate with quant or diaries, and interpret in cultural context.","categories":["Fieldwork","Operations"],"primary":"Fieldwork"},
    {"id":"Q60","question":"What should we be mindful of to ensure that participants feel comfortable sharing their thoughts during a group interview in Japan?","answer":"Set norms, manage turn-taking, and use warm-up rounds; watch hierarchy effects and ensure psychological safety.","categories":["Fieldwork","Operations","HCP","Patients"],"primary":"Fieldwork"},
    {"id":"Q61","question":"What considerations or precautions should overseas clients keep in mind when observing interviews or focus groups conducted in Japan?","answer":"Brief observers on etiquette; avoid visible reactions; use backroom chat discreetly; protect anonymity and consent.","categories":["Fieldwork","Operations","Compliance"],"primary":"Fieldwork"},
    {"id":"Q62","question":"What legal and ethical considerations are necessary when conducting market research in the healthcare field in Japan?","answer":"Follow national laws, industry codes, and data protection guidelines; obtain informed consent and avoid promotional framing.","categories":["Compliance"],"primary":"Compliance"},
    {"id":"Q63","question":"What should be considered regarding the handling of personal information when conducting healthcare-related market research in Japan?","answer":"Minimize PII, use anonymized IDs, secure storage, and controlled access; share aggregated insights only.","categories":["Compliance","Operations"],"primary":"Compliance"},
    {"id":"Q64","question":"When requesting participation from healthcare professionals or patients in Japan, how should informed consent be obtained, and what key points should be explained to them?","answer":"Explain purpose, data use, recording, confidentiality, and incentives; obtain written or verifiable digital consent.","categories":["Compliance","Fieldwork","HCP","Patients"],"primary":"Compliance"},
    {"id":"Q65","question":"Is it acceptable to provide honoraria to physicians and patients for participating in market research in Japan? What criteria should be used to determine appropriate compensation?","answer":"Yes within ethical standards; base amounts on time, expertise, and market benchmarks; document methods and taxes.","categories":["Compliance","Operations","HCP","Patients"],"primary":"Compliance"},
    {"id":"Q66","question":"Are there any considerations to keep in mind when setting the schedule for a research project commissioned to a Japanese research agency?","answer":"Account for holidays, approvals, translation/ICR time, and clinic hours; build buffers for recruitment.","categories":["Timeline","Operations"],"primary":"Timeline"},
    {"id":"Q67","question":"How can the expertise of analysts and Key Opinion Leader (KOL) networks within Japanese research agencies be effectively utilized in healthcare research?","answer":"Engage early for screener/refinement and sampling; leverage KOLs for feasibility checks and interpretation.","categories":["Operations","HCP","Fieldwork"],"primary":"Operations"},
    {"id":"Q68","question":"In Japan, is it possible to recruit physicians from a target list?","answer":"Possible with compliance and permissions; confirm list source/consent, avoid unsolicited contact, and align with codes.","categories":["Compliance","Fieldwork","HCP","Operations"],"primary":"Compliance"}
  );
  // ★ ここまでFAQ本体

})();
